AstraZeneca plc (ADR) (AZN), Sanofi SA (ADR) (SNY): Don’t Ignore These European Healthcare Stocks

Page 1 of 2

Healthcare stocks have rallied over the past couple years, and for good reason. Not only is the global economy gaining traction, but the demographic trends, particularly in the United States, are extremely favorable. It’s a cliché by now, but it’s still true, that America is an aging society. The Baby Boomer generation is rapidly approaching retirement, and in turn will require a great deal of healthcare services.

As a result, when many investors view healthcare stocks, they tend to focus on the U.S. pharmaceutical giants. While those companies are certainly worthy of investment consideration, there happen to be foreign companies with significant exposure to the U.S. economy that are equally worthy of your investment dollars.

AstraZeneca plc (ADR) (NYSE:AZN)

Profits from across the pond

You may not know these international pharmaceutical giants, but they have the same characteristics that make their American counterparts so attractive: namely, steady fundamentals and hefty dividend yields.

In some cases, these healthcare giants may actually provide more in terms of yield than their U.S. peers. For example, AstraZeneca plc (ADR) (NYSE:AZN) carries one of the biggest yields among the publicly-traded big pharma stocks.

Based in the United Kingdom, AstraZeneca plc (ADR) (NYSE:AZN) might not sound familiar to many investors, but many of its key products probably ring a bell. Among the company’s better known drugs are Crestor, Nexium, and Atacand.

As previously mentioned, perhaps the best feature of owning AstraZeneca plc (ADR) (NYSE:AZN) is its massive dividend. The company pays a semi-annual dividend, which yields close to 6% annualized.

Furthermore, AstraZeneca plc (ADR) (NYSE:AZN) isn’t expensively valued. Whereas many U.S. pharmaceutical giants trade close to 20 times trailing earnings, AstraZeneca plc (ADR) (NYSE:AZN) changes hands for a much more attractive 10 times trailing EPS.

Other international candidates for your watch list are Novartis AG (ADR) and Sanofi SA (ADR) (NYSE:SNY). Both of these companies are giants, with the market values and dividends to prove it.

Novartis AG (ADR) is based in Switzerland and has a long history, founded all the way back in 1895. The company holds a $173 billion market capitalization.

Novartis AG (ADR) reported mixed full-year 2012 results. Sales were flat on a constant currency basis, but core earnings per share dropped 3% versus the prior year. However, Novartis AG (ADR) was pleased with its performance amid the challenging 2012 economy and provided investors with the 16th consecutive annual dividend increase. The company’s current payout yields 3.5% at recent prices.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 8 Best Halloween Decorating Ideas to Spook Up Your House

10 Marvel Women that Should Get a Movie Right Now

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

The 10 Most Expensive Clothing Stores in the United States to Get Decked Out At

The 5 Biggest Kickstarter Scams That Swindled Backers’ Donations

The 10 Most Expensive Boarding Schools In the World

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

Top 6 Cities For The Ultra Rich to Live in Comfort

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!